Brent T Harris, MD, PhD

Dr. Harris is a tenured academic neuropathologist and physician-scientist with diverse interests and collaborations in team science studying neoplastic and neurological conditions. In his own NIH and foundation funded laboratory he investigates the pathogenesis and pathophysiology of several neurological diseases with the goal of discovering new mechanisms and targets for drug therapy. His graduate training in neuropharmacology combined with my medical training in neuropathology has allowed him to approach such diseases/conditions as ALS, FTLD, traumatic brain injury, Alzheimer disease and CNS neoplasia with an eye towards translation of basic mechanisms of disease into therapy. A major goal in his laboratory is to understand how neuroinflammation, senescence, and glial-neuronal signaling may be important in CNS aging biology and disease. Dr. Harris is the Director of Neuropathology, the Georgetown Brain Bank, and the Histopathology and Tissue Shared Resource (HTSR) at GU, co-Director for the Target ALS PM core, member of the NEALS biorepository comm, and lead neuropathologist/M-PI for the ALL ALS program.